The Non-Financial Ledger

For the people at the center of this lawsuit, a hotel lobby is not a neutral space. It is a place where the air itself has been weaponized against their bodies, and where the choice is to stay away or to get sick.

According to the complaint, plaintiffs Holly Fraley and Nancy Copley suffer from chemical sensitivities that substantially limit their ability to breathe and concentrate. When exposed to fragrance, the filing states, they and class members experience migraines, asthma attacks, skin irritation, gastrointestinal distress, cardiovascular symptoms, and cognitive problems. The complaint describes the fear and apprehension of encountering fragrance as “intense” for disabled people, before the physical reactions even begin.

The betrayal is quiet and expensive. The complaint says class members spend “considerable” time researching which businesses are safe, pleading with staff to turn off scent machines, and traveling to hotels only to be effectively turned away. They lose the ordinary freedom to meet family and friends in public places that everyone else takes for granted.

Legal Receipts

These are the words of the complaint itself. Every quote below is drawn verbatim from the filing.

“Despite actual or constructive knowledge of the toxic properties of Synthetic fragranced consumer products, Defendant flooded its common and private areas with said products, thereby showering unsuspecting customers, employees, guests, vendors and/or patrons with substances known to cause respiratory problems, headaches, skin irritation, and adverse gastrointestinal, cardiovascular and cognitive reactions.”

• This is the core accusation: the harm was not accidental leakage but a deliberate flooding of both public and private spaces.
• It alleges Loews had knowledge of the toxicity before exposing people, which sets up the fraudulent concealment claim.
• It names the specific bodily harms the plaintiffs attribute directly to the fragrance.

“For purposes of branding, manufacturing an [illusory] association between said fragranced products and the quality of Defendant’s Facilities—purposes calculated singularly to maximize revenue and profitability and not to promote a healthy and safe consumer experience—Defendant exposed tens of thousands [even at a conservative estimate] of individuals to these pollutants, without warning…”

• The filing frames the motive as profit and image, not customer wellbeing.
• It puts a scale on the alleged harm: “tens of thousands” of people, described as a conservative estimate.
• The phrase “without warning” is central to the failure-to-disclose theory of the case.

“the toxins have already been ingested, have landed upon the skin, have entered the lungs and, thus, entered these victims’ bloodstreams (by design) and targeted various organs/systems.”

• The complaint alleges the sub-micron particle design is intended to bypass the body’s natural filtering.
• The words “by design” argue this is a foreseeable, engineered outcome, not an unfortunate side effect.
• It supports the claim that first-time visitors cannot protect themselves because exposure happens before they can react.

“No individual shall be discriminated against on the basis of disability in the full and equal enjoyment of the goods, services, facilities, privileges, advantages, or accommodations of any place of public accommodation by any person who owns, leases (or leases to), or operates a place of public accommodation.”

• This is the ADA text (42 U.S.C. § 12182(a)) the entire case is built on.
• The plaintiffs argue that a hotel is a “place of public accommodation” and that fragrance denies disabled people equal enjoyment of it.
• It anchors the demand for a permanent injunction rather than individual money damages.

“the toxins have already been ingested, have landed upon the skin, have entered the lungs and, thus, entered these victims’ bloodstreams (by design) and targeted various organs/systems.”

What Loews Said vs. What the Suit Alleges

The complaint contrasts Loews’ public promises of accessibility and safety against what it claims was happening in the air of its hotels.

• Loews’ website states it is “committed to providing individuals with disabilities equal access to [its] goods, services, and facilities,” while the suit alleges the fragrance practice categorically blocked chemically disabled people from safe access.
• Loews promises “reasonable modifications to [its] policies, practices, and procedures,” while the complaint says it failed to modify the fragrance policy that was making disabled guests sick.
• The company markets its facilities as “safe and accessible to all,” while the filing alleges the air contained VOCs, aldehydes, phthalates, and secondary pollutants like formaldehyde.
• Nowhere in Loews’ advertising, the complaint says, is there any mention of fragrance use or its harms, denying the public the information needed to make an informed choice.

Regulatory Gray Zones: The Loophole in the Air

The complaint argues that Loews operated inside a deliberate gap where almost no U.S. agency polices commercial fragrance in public spaces.

• The filing cites “the paucity of oversight (e.g., by the Occupational Safety and Health Administration and/or the Food and Drug Administration) of the commercial use of fragrance in places of public accommodations.”
• U.S. cosmetic rules do not require listing individual fragrance allergens, so compounds like limonene, linalool, and citral can be hidden under the single word “Fragrance.”
• The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) and the industry’s own International Fragrance Association focus on cosmetic labeling, not fragrance dispersed into the air of hotels.
• Fragrance formulas are frequently claimed as “trade secrets,” meaning even some businesses using them may not know exactly which dangerous compounds they are releasing.
• The complaint notes the European Union requires disclosure of many fragrance allergens, while in the U.S. the composition “remains largely hidden.”

Profit-Maximization at All Costs

The complaint’s central financial claim is blunt: fragrance was cheaper than fixing the real problem, and the harm was accepted as a cost of doing business.

• The filing states that for many businesses “it is oftentimes cheaper to introduce Synthetic fragranced consumer products than to fix (e.g., shampoo and/or replace old carpets, improve water drainage, repair leaks) the source of the initial health concern.”
• It alleges the scent was used to “mask odors such as mold” and to “trick visitors into associating Defendant’s Facilities with cleanliness,” creating a false perception rather than an actual one.
• The complaint says the purpose was “calculated singularly to maximize revenue and profitability and not to promote a healthy and safe consumer experience.”
• It alleges Loews could “easily and inexpensively decommission” the systems, meaning the harm continued despite a cheap fix being available.
• The suit notes hotels even sell their “signature scents” in gift shops and online, turning the alleged hazard into an additional revenue stream.

Legal Minimalism: The Letter but Not the Spirit

The complaint argues Loews checked accessibility boxes on paper while running a practice that defeated the entire purpose of disability access law.

• The ADA (42 U.S.C. § 12182) exists to guarantee “full and equal enjoyment” of public accommodations; the suit alleges Loews advertised compliance while making its air unusable for chemically disabled guests.
• Loews reportedly offers “accessible rooms” and posts an accessibility commitment, satisfying visible ADA formalities while, the complaint says, the fragrance in the shared air rendered the space inaccessible.
• The filing points to Loews’ existing smoking bans as proof it knows how to remove airborne hazards when motivated, arguing the company followed one health law’s spirit while ignoring the same principle for fragrance.
• Because federal cosmetic labeling law technically permits hiding ingredients under “Fragrance,” the suit alleges Loews leaned on that permission to avoid disclosing what it was dispersing.

How Capitalism Exploits Delay: Time as a Weapon

The complaint describes a practice allowed to run “unabated for years” and warns that even removing the machines now would not stop Loews from switching them back on.

• The filing states Defendant “had full knowledge of the dangerous nature of said compounds and permitted same to continue unabated for years,” invoking fraudulent concealment to toll the statute of limitations.
• The complaint compares the situation to the “long lag time between knowledge of the dangers of second-hand smoke and the resulting smoking bans,” arguing public harm outran regulation.
• It argues that without a court injunction, Loews “is not presently enjoined from” resuming fragrance use even if it pauses during litigation, so voluntary removal offers no lasting protection.
• The suit notes many class members “could not have reasonably discovered the toxic nature of these chemicals,” meaning the delay in discovery was built into the concealment itself.

Supply Chain Complicity: The Scent Vendors

The fragrance did not originate with Loews. The complaint implicates the vendors and manufacturers who supplied the machines, tubes, and chemical formulas.

• The filing describes a “multitude of vendors” offering scent dispersion machines (SDMs) and air supply tubes that integrate with HVAC systems to atomize fragrance across selected zones.
• It alleges Loews’ selection of a specific product “implies an exchange of information between Defendant and the manufacturer and/or distributor thereof regarding the chemical components and associated safety risks.”
• The complaint says Defendant “knew and/or should have known” the dangers, including “by questioning its fragranced product suppliers,” placing a duty on Loews to interrogate its vendors.
• It notes manufacturers and “their partner organizations” produce concentrated fragrance tubes, and that a marketplace exists for copying popular hotels’ “signature scents,” spreading the practice across the industry.

The Contractor Shield: Parent and Subsidiary

The complaint names both the parent and its wholly-owned subsidiary, targeting a corporate structure that could otherwise diffuse responsibility.

• The filing states that “Loews Hotels Holding Corporation is a wholly-owned subsidiary of Defendant Loews Corporation,” and sues both entities together as a single “Defendant.”
• The suit reserves the right to add “all parties that exercise control over the environmental conditions” of Loews’ U.S. locations, anticipating attempts to point at operators or franchisees.
• By naming the parent corporation directly, the complaint aims to prevent liability from being isolated in a subsidiary that continues profiting from the branded scent.
• The action seeks relief “against all of Defendant’s locations in the United States,” not just individual hotels, to stop the structure from shielding conduct site by site.

Manufactured Consent: Selling the Scent

The complaint argues the fragrance industry has built a marketing machine that presents toxic scent as a mark of quality and safety.

• The suit describes “signature scents” being sold in gift shops, spa centers, and online portals, which it says “further bolsters the message that fragrance is safe when it is, in fact, not safe.”
• It notes a whole marketplace exists for businesses “wishing to emulate the ‘signature scents’ already in use at, e.g., popular hotels,” spreading the perception that branded scent equals prestige.
• The filing calls out the International Fragrance Association as “[c]reated by the fragrance industry for the fragrance industry,” arguing it “lacks the neutrality necessary to objectively evaluate and/or curb fragrance use.”
• It contrasts this with the “uptick in ‘fragrance free’ advertisements” on television, arguing public awareness of the danger is growing despite industry messaging.

Societal Impact Mapping

Public Health

The complaint frames synthetic fragrance as a widespread indoor air pollution problem affecting far more than the named plaintiffs.

• The filing states that “roughly one-third of people in the United States experience noticeable adverse health effects” from synthetic fragranced products, citing a 34.7% figure.
• It reports 27.5% of American adults suffer from Chemical Sensitivity, of whom 78.9% reported adverse effects from fragrance exposure.
• Among people with asthma (26.8% of adults), the complaint says 57.8% reported adverse effects and 62.8% reported being further disabled, such as losing work time or a job.
• The suit links fragrance chemicals to formaldehyde and acetaldehyde, classified as hazardous under federal law and California’s Proposition 65, and to development of asthma and COPD.
• It cites phthalates as endocrine disruptors “particularly dangerous for women of childbearing age,” linked to birth defects and developmental disorders.

Economic Inequality

The complaint documents how fragrance imposes real, unequal costs on disabled people just to move through public life.

• Class members reportedly avoid fragranced businesses entirely, cutting them off from lodging, dining, and social venues open to everyone else.
• They spend “a considerable amount of time” researching safe venues and pleading with staff, an unpaid burden non-disabled people never carry.
• The filing says people travel to businesses “just to be, effectively, turned away,” incurring “considerable expense, embarrassment and inconvenience.”
• Among those with Chemical Sensitivity, 28.6% reported losing workdays or a job in the past year due to workplace fragrance exposure.
• The complaint states fragrance is “not merely physiologically debilitating, but also socially, reputationally and economically limiting.”

This Is the System Working as Intended

The complaint itself argues the harm exists precisely because the rules were built to let it.

• The filing describes a “regulatory and legislative void” in which OSHA and the FDA barely touch commercial fragrance in public accommodations, leaving businesses free to disperse it.
• It notes the only U.S. framework on point, cosmetic labeling law, lets companies hide ingredients under the word “Fragrance,” so nondisclosure is legal by default.
• The suit points out the fragrance industry’s main standards body, IFRA, is “[c]reated by the fragrance industry for the fragrance industry,” meaning self-regulation replaces neutral oversight.
• The complaint argues that because no agency has banned the practice, injunctive relief through the courts is the only immediate protection available to disabled guests.

What a Legitimate Fix Looks Like

The core failure this case exposes is that harmful chemicals can be sprayed into shared public air with no disclosure and almost no oversight. The following are our editorial recommendations, not findings of the complaint.

Regulatory Track

• OSHA and the FDA should establish clear standards for commercial fragrance dispersion in public accommodations, closing the oversight gap the complaint identifies.
• Require mandatory posted disclosure at building entrances whenever scent dispersion machines are in use, so disabled guests can make informed choices before exposure.
• Mandate that scent vendors provide full Safety Data Sheets and ingredient disclosure to purchasing businesses, ending the “trade secret” shield across the supply chain.

Legislative Track

• Adopt EU-style fragrance allergen disclosure requirements so compounds like limonene and linalool cannot hide behind the single word “Fragrance.”
• Expand fragrance-free protections in public accommodations modeled on existing smoking bans, which the complaint cites as proof such rules are workable.
• Clarify under the ADA that intentionally dispersing airborne hazards into shared spaces is a form of access denial for chemically disabled people.

Corporate Governance Track

• Loews should decommission all fragrance dispersion systems and adopt a written fragrance-free policy for staff and guests, which the complaint says can be done “easily and inexpensively.”
• Fix the underlying conditions, such as mold and old carpeting, that fragrance was allegedly used to mask, rather than covering odors with chemicals.
• Add an accessibility and indoor-air-quality compliance review to executive accountability, so profit-driven branding choices cannot override guest health.

What Now?

Direct your attention toward the named defendants, Loews Corporation and Loews Hotels Holding Corporation, and the agencies that could close the fragrance oversight gap.

• Watchlist: The FDA, which the complaint says provides minimal oversight of commercial fragrance and controls cosmetic ingredient rules under MoCRA.
• Watchlist: OSHA (and state equivalents like Cal/OSHA), named in the filing for the “paucity of oversight” of workplace and public-accommodation fragrance exposure.
• If you have chemical sensitivity, document your exposures at hotels and file complaints with the DOJ’s ADA enforcement channels and state disability-rights offices.
• Support disability-rights and chemical-sensitivity groups organizing for fragrance-free public spaces, and share safe-venue information through local mutual aid networks.
• Push your workplace, school, and local venues to adopt written fragrance-free policies, using the CDC’s own internal ban cited in the complaint as a model.